Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 6Educational Status 4Resistance Training 3Exercise 3Transcutaneous Electric Nerve Stimulation 2Standard of Care 2Radiotherapy 2Mouthwashes 2Methods 2Megestrol Acetate 2Early Intervention, Educational 2Counseling 2semaglutide 1naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Xylitol 1Weights and Measures 1Vitamin D 1Tablets 1Surveys and Questionnaires 1Stents 1Spermine Synthase 1Specimen Handling 1Psychiatric Rehabilitation 1Progestins 1Practice Guidelines as Topic 1Population Groups 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Estrogen Replacement Therapy × Other × 90 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡